All Stories

  1. Are the UK’s Vitamin C Recommendations Evidence-Based? A Critical Comment
  2. Estimating quantile treatment effect on the original scale of the outcome variable: a case study of common cold treatments
  3. Vitamin C in infectious diseases: Misrepresentation of the evidence
  4. Misleading summary of the Cochrane review on zinc for the common cold (2024)
  5. Errors in a Meta-analysis on Vitamin C and COVID-19
  6. Vitamin C for the common cold and pneumonia
  7. Shortcomings in the Cochrane review on zinc for the common cold (2024)
  8. Vitamin C for patients with sepsis?
  9. Evidence-based treatment of the common cold with zinc lozenges
  10. Rebound effect explains the divergence in survival after 5 days in a controlled trial on vitamin C for COVID-19 patients
  11. Response: Commentary: Quantile treatment effect of zinc lozenges on common cold duration: a novel approach to analyze the effect of treatment on illness duration
  12. Vitamin C deficiency can lead to pulmonary hypertension: a systematic review of case reports
  13. Vitamin C reduces the severity of common colds: a meta-analysis
  14. Concerns with the revised Japanese recommendation for administering vitamin C to septic patients
  15. Vitamin C may reduce troponin and CKMB levels after PCI and CABG: a meta-analysis
  16. Zinc and Coronavirus Disease 2019
  17. Vitamin C: abrupt termination may increase mortality of sepsis patients
  18. Pitfalls in choosing data examples for methodological work: Bayesian approaches to a fixed effects meta‐analysis of zinc lozenges for the common cold
  19. Vitamin C and the risk of atrial fibrillation: Mendelian randomization study may be misleading
  20. Vitamin C and the risk of cardiovascular diseases: Mendelian randomization study may be misleading
  21. Vitamin C may improve the mechanical efficiency of the heart
  22. Mendelian randomization can lead to flawed conclusions about the effects of vitamin C
  23. Quantile treatment effect of zinc lozenges on common cold duration: a novel approach
  24. Bias against vitamin C has hampered the recognition of positive findings from randomized trials
  25. Vitamin C and zinc lozenges for COVID-19?
  26. Carrageenan nasal spray can shorten the common cold and the effect is greater on longer colds
  27. Vitamin C May Increase the Recovery Rate of Outpatient Cases of SARS-CoV-2 Infection by 70%: Reanalysis of the COVID A to Z Randomized Clinical Trial
  28. Commentary: The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19
  29. Vitamin C may increase the recovery rate of outpatient cases of SARS-CoV-2 infection by 70%: reanalysis of the COVID A to Z Randomized Clinical Trial
  30. Commentary: Vitamin C supplementation for prevention and treatment of pneumonia
  31. Vitamin C and COVID-19
  32. Benefit of OTC Formula Against COVID-19 Is Explained by Selection Bias
  33. Comment on “Therapeutic target and molecular mechanism of vitamin C-treated pneumonia: a systematic study of network pharmacology” by R. Li, C. Guo, Y. Li, X. Liang, L. Yang and W. Huang, Food Funct., 2020, 11, 4765
  34. Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: re-analysis of randomized trial data
  35. Reanalysis of the Effect of Vitamin C on Mortality in the CITRIS-ALI Trial: Important Findings Dismissed in the Trial Report
  36. Cochrane has not consistently followed the COPE guidelines
  37. The current vitamin E recommendation in the USA is not supported by new empirical evidence
  38. Vitamin C for Cardiac Surgery Patients: Several Errors in a Published Meta-Analysis. Comment on “Effects of Vitamin C on Organ Function in Cardiac Surgery Patients: A Systematic Review and Meta-Analysis. Nutrients 2019, 11, 2103”
  39. Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: a meta-regression analysis
  40. Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trial
  41. The effect of β-carotene on the mortality of male smokers is modified by smoking and by vitamins C and E: evidence against a uniform effect of nutrient
  42. Vitamin C as a Possible Therapy for COVID-19
  43. Many continuous variables should be analyzed using the relative scale: a case study of β2-agonists for preventing exercise-induced bronchoconstriction
  44. Zinc for preventing and treating the common cold
  45. Meta-analysis on vitamin C and the common cold in children may be misleading
  46. Random-Effects Assumption in Meta-analyses
  47. Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis
  48. Errors in a meta-analysis on vitamin C and post-operative atrial fibrillation
  49. Effect of β-Carotene Supplementation on the Risk of Pneumonia Is Heterogeneous in Males: Effect Modification by Cigarette Smoking
  50. Letter: Comparison of different vitamin E forms is confounded by heterogeneity in vitamin E effects
  51. Vitamin C in Clinical Therapeutics
  52. Zinc for preventing and treating the common cold
  53. Erroneus calculation of sample size in a vitamin C and atrial fibrillation trial
  54. Duration of the common cold and similar continuous outcomes should be analyzed on the relative scale: a case study of two zinc lozenge trials
  55. Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage
  56. Vitamins E and C May Differ in Their Effect on Contrast-Induced Acute Kidney Injury
  57. Vitamin E May Protect Against Contrast-Induced Acute Kidney Injury
  58. Vitamin C and Infections
  59. Publication bias in meta-analysis of ascorbic acid for postoperative atrial fibrillation
  60. Vitamin C for preventing atrial fibrillation in high risk patients: a systematic review and meta-analysis
  61. Zinc lozenges may triple the recovery rate of common cold patients
  62. Vitamin E and the risk of pneumonia: using the I 2 statistic to quantify heterogeneity within a controlled trial
  63. Many continuous variables such as the duration of the common cold should be analyzed using the relative scale
  64. Vitamin E administration may decrease the incidence of pneumonia in elderly males
  65. Zinc acetate lozenges may shorten common cold duration by 3 days
  66. Vitamin C for treating atrial fibrillation
  67. Thomas Chalmers, vitamin C and the common cold
  68. Zinc lozenges and vitamin C for the common cold are not examples of placebo effect in action
  69. Common Cold Treatment Using Zinc
  70. Impure placebo is a useless concept
  71. Exercise, Antioxidants, and the Risk for Pneumonia
  72. Zinc acetate lozenges may shorten common cold-associated nasal discharge by 34% and cough by 46%
  73. Vitamin D Supplementation and Upper Respiratory Tract Infections in Adolescent Swimmers: A Randomized Controlled Trial
  74. Vitamin C for treating atrial fibrillation
  75. The effect of vitamin C on bronchoconstriction and respiratory symptoms caused by exercise: a review and statistical analysis
  76. Vitamin C and asthma
  77. Clinical use of placebo treatments may undermine the trust of patients: a response to Gold and Lichtenberg
  78. Vitamin and Mineral Supplements in the Primary Prevention of Cardiovascular Disease and Cancer
  79. Can CAM treatments be evidence‐based?
  80. Does Exercise Prevent the Common Cold?
  81. The Effect of Vitamin E on Mortality Is Not Uniform across the Population
  82. Vitamin C Should Be Tested against Exercise-induced Bronchoconstriction
  83. Vitamin C and common cold-induced asthma: a systematic review and statistical analysis
  84. Vitamin C for preventing and treating tetanus
  85. Meta-Regression Analyses, Meta-Analyses, and Trial Sequential Analyses of the Effects of Supplementation with Beta-Carotene, Vitamin A, and Vitamin E Singly or in Different Combinations on All-Cause Mortality: Do We Have Evidence for Lack of Harm?
  86. Vitamin C for preventing and treating pneumonia
  87. Vitamin supplements and mortality in older people
  88. Vitamin C may alleviate exercise-induced bronchoconstriction: a meta-analysis
  89. Placebo Use in the United Kingdom: Results from a National Survey of Primary Care Practitioners
  90. Vitamin C for preventing and treating the common cold
  91. Zinc lozenges may shorten common cold duration
  92. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials
  93. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
  94. Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density
  95. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
  96. Erratum to: Vitamin C and asthma in children: modification of the effect by age, exposure to dampness and the severity of asthma
  97. Vitamin C and Community-acquired Pneumonia
  98. Zinc Lozenges Shorten Colds
  99. The Effect of Vitamin C on the Common Cold
  100. Zinc for the common cold
  101. Subgroup analysis of large trials can guide further research: a case study of vitamin E and pneumonia
  102. Vitamin E may affect the life expectancy of men, depending on dietary vitamin C intake and smoking
  103. Vitamin C and asthma in children: modification of the effect by age, exposure to dampness and the severity of asthma
  104. Rabies, Still Neglected after 125 Years of Vaccination
  105. Randomised trials on vitamin C
  106. The effect of β-carotene on common cold incidence is modified by age and smoking: evidence against a uniform effect in a nutrient–disease relationship
  107. The effect of vitamin C on upper respiratory infections in adolescent swimmers: a randomized trial
  108. There is no alternative medicine
  109. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
  110. Vitamin C and the treatment of tetanus
  111. Vitamin C for the common cold should not be rejected on the basis of old and erroneous articles
  112. Vitamin D Level, Respiratory Tract Infections, and Controlled Trials
  113. Vitamin E is likely to affect mortality even at low doses
  114. Predicting the incidence of human campylobacteriosis in Finland with time series analysis
  115. Modification of the Effect of Vitamin E Supplementation on the Mortality of Male Smokers by Age and Dietary Vitamin C
  116. Letter to the Editor
  117. Vitamin C supplementation for asthma
  118. Vitamins and minerals
  119. Vitamin C and exercise-induced bronchoconstriction in athletes
  120. Evidence-based medicine and the role of antioxidants in physically stressed people
  121. Vitamin E supplementation and pneumonia risk in males who initiated smoking at an early age: effect modification by body weight and dietary vitamin C
  122. Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake
  123. Cochrane review: Vitamin C for preventing and treating the common cold
  124. Commentaries on ‘Vitamin C for preventing and treating the common cold’ with responses from the review author
  125. Assessment of the importance of double‐blinding should be based on systematic reviews: a rebuttal
  126. Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake – reply by Hemilä & Kaprio
  127. Vitamin C for preventing and treating tetanus
  128. Vitamin C and sex differences in respiratory tract infections
  129. THE AUTHOR REPLIES
  130. Exercise, Vitamins and Respiratory Tract Infections
  131. Vitamin C may affect lung infections
  132. Vitamin C may affect lung infections
  133. Antioxidant Supplements and Mortality
  134. VITAMIN E SUPPLEMENTATION AND RESPIRATORY INFECTIONS IN OLDER PEOPLE
  135. Vitamin C for preventing and treating tetanus
  136. Vitamin C for preventing and treating the common cold
  137. Evidence-based medicine and vitamin E supplementation
  138. Vitamin C and exercise-induced immunodepression
  139. RE: "BIAS IN CLINICAL INTERVENTION RESEARCH"
  140. Conclusions about intervention effects should not be based on surrogate end points
  141. Vitamin C for preventing and treating pneumonia
  142. Small trials focusing on surrogate end points may be uninformative
  143. Letter to the Editor
  144. The Effect of Vitamin E on Common Cold Incidence Is Modified by Age, Smoking and Residential Neighborhood
  145. Physical Activity and the Risk of Pneumonia in Male Smokers Administered Vitamin E and β-Carotene
  146. Analysis of clinical data with breached blindness by Shein-Chung Chow and Jun Shao,Statistics in Medicine 2004;23:1185–1193
  147. The Protective Effect of Vitamins A and C on Endotoxin-Induced Oxidative Renal Tissue Damage in Rats
  148. Potential harm of vitamin E supplementation
  149. Vitamin C for preventing and treating pneumonia
  150. Authors' Reply
  151. Misleading Information on the Properties of Vitamin C
  152. Echinacea, Vitamin C, the Common Cold, and Blinding
  153. Assessment of blinding may be inappropriate after the trial
  154. Allocation concealment and blinding: when ignorance is bliss
  155. High-Dosage Vitamin E Supplementation and All-Cause Mortality
  156. High-Dosage Vitamin E Supplementation and All-Cause Mortality
  157. Vitamin C for Preventing and Treating the Common Cold
  158. Vitamin E and Respiratory Tract Infections in Elderly Persons
  159. Vitamin C Supplementation and Respiratory Infections: a Systematic Review
  160. Vitamin C for preventing and treating the common cold
  161. Vitamin E and Beta-Carotene Supplementation and Hospital-Treated Pneumonia Incidence in Male Smokers
  162. Vitamin C and SARS coronavirus
  163. Vitamin C, respiratory infections and the immune system
  164. Physical Activity and the Common Cold in Men Administered Vitamin E and ??-Carotene
  165. Vitamin C, Vitamin E, and Beta-Carotene in Relation to Common Cold Incidence in Male Smokers
  166. Vitamin C and Other Compounds in Vitamin C Rich Food in Relation to Risk of Tuberculosis in Male Smokers
  167. Vitamin C supplementation and common cold symptoms: factors affecting the magnitude of the benefit
  168. Vitamin C and Infectious Diseases
  169. Nutrition Discussion Forum
  170. Vitamin C intake and susceptibility to pneumonia
  171. Blood donation, body iron stores, and risk of myocardial infarction
  172. Vitamin C intake and susceptibility to the common cold
  173. Vitamin C supplementation and common cold symptoms: Problems with inaccurate reviews
  174. To the dissent by Thomas Chalmers
  175. Vitamin C, the placebo effect, and the common cold: A case study of how preconceptions influence the analysis of results
  176. Vitamin C and Common Cold Incidence: A Review of Studies with Subjects Under Heavy Physical Stress
  177. Vitamin C and the common cold: a retrospective analysis of Chalmers' review.
  178. THE GOOD AND HARM OF VITAMIN C
  179. Does Vitamin C Alleviate the Symptoms of the Common Cold? - A Review of Current Evidence
  180. Hormone-sensitive lipase is closely related to several bacterial proteins, and distantly related to acetylcholinesterase and lipoprotein lipase: Identification of a superfamily of esterases and lipases
  181. Cloning and sequencing of a gene encoding acidophilic amylase from Bacillus acidocaldarius
  182. Vitamin C, cholesterol, and the nutritional recommendations
  183. Improving the production of E. coli β-lactamase in Bacillus subtilis: the effect of glucose, pH and temperature on the production level
  184. Sequence encoding ribosomal protein L33 of Lactococcus lactis
  185. VITAMIN C, NEUTROPHILS AND THE SYMPTOMS OF THE COMMON COLD
  186. Expression of the Erwinia carotovora polygalacturonase-encoding gene in Bacillus subtilis: role of signal peptide fusions on production of a heterologous protein
  187. Vitamin C and the common cold
  188. Vitamin C and plasma cholesterol
  189. Lipoamide dehydrogenase of Staphylococcus aureus: nucleotide sequence and sequence analysis
  190. Vitamin C and lowering of blood pressure: need for intervention trials?
  191. Nucleotide sequence of a Lactococcus lactis gene cluster encoding adenylate kinase, initiation factor 1 and ribosomal proteins
  192. Production of heterologous proteins in Bacillus subtilis: the effect of the joint between signal sequence and mature protein on yield
  193. Nucleotide sequence of the secY gene from Lactococcus lactis and identification of conserved regions by comparison of four SecY proteins
  194. Sequence of a PAL-related lipoprotein fromBacillus subtilis
  195. Sequence of a PAL-related lipoprotein from Bacillus subtilis
  196. Production of pectin methylesterase from Erwinia chrysanthemi B374 in Bacillus subtilis
  197. Is there a biochemical basis for ‘nutrient need’?
  198. The secretory S complex in Bacillus subtilis is identified as pyruvate dehydrogenase
  199. Secretory S complex of Bacillus subtilis: sequence analysis and identity to pyruvate dehydrogenase.
  200. Production of diphtheria toxin CRM228 in B. subtilis
  201. Production of diphtheria toxin CRM228 inB. subtilis
  202. A re-evaluation of nutritional goals -not just deficiency counts
  203. Retinoids Activate Superoxide Production by Polymorphonuclear Leucocytes
  204. Activated polymorphonuclear leucocytes consume vitamin C
  205. Nutritional need versus optimal intake